Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Concentrix (CNXC) Cash & Equivalents (2020 - 2025)

Concentrix's Cash & Equivalents history spans 5 years, with the latest figure at $240.6 million for Q4 2024.

  • For Q4 2024, Cash & Equivalents fell 18.54% year-over-year to $240.6 million; the TTM value through Nov 2024 reached $240.6 million, down 18.54%, while the annual FY2024 figure was $240.6 million, 18.54% down from the prior year.
  • Cash & Equivalents for Q4 2024 was $240.6 million at Concentrix, down from $295.3 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $295.3 million in Q4 2023 and bottomed at $86.8 million in Q1 2020.
  • The 5-year median for Cash & Equivalents is $155.6 million (2021), against an average of $156.6 million.
  • The largest annual shift saw Cash & Equivalents soared 87.56% in 2023 before it decreased 18.54% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $156.4 million in 2020, then rose by 17.05% to $183.0 million in 2021, then decreased by 13.96% to $157.5 million in 2022, then surged by 87.56% to $295.3 million in 2023, then fell by 18.54% to $240.6 million in 2024.
  • Per Business Quant, the three most recent readings for CNXC's Cash & Equivalents are $240.6 million (Q4 2024), $295.3 million (Q4 2023), and $157.5 million (Q4 2022).